| Literature DB >> 29767289 |
Samaneh Hosseini1, Leila Taghiyar1, Fatemeh Safari2, Mohamadreza Baghaban Eslaminejad3.
Abstract
A major research challenge is to develop therapeutics that assist with healing damaged tissues and organs because the human body has limited ability to restore the majority of these tissues and organs to their original state. Tissue engineering (TE) and regenerative medicine (RM) promises to offer efficient therapeutic biological strategies that use mesenchymal stem cells (MSCs). MSCs possess the capability for self-renewal, multilineage differentiation, and immunomodulatory properties that make them attractive for clinical applications. They have been extensively investigated in numerous preclinical and clinical settings in an attempt to overcome their challenges and promote tissue regeneration and repair. This review explores the exciting opportunities afforded by MSCs, their desirable properties as cellular therapeutics in RM, and implicates their potential use in clinical practice. Here, we attempt to identify challenges and issues that determine the clinical efficacy of MSCs as treatment for skeletal and non-skeletal tissues.Entities:
Keywords: Clinical setting; Mesenchymal stem cells; Non-skeletal tissues; Regenerative medicine; Skeletal tissues
Mesh:
Year: 2018 PMID: 29767289 DOI: 10.1007/5584_2018_213
Source DB: PubMed Journal: Adv Exp Med Biol ISSN: 0065-2598 Impact factor: 2.622